Insulin Market 2026: Strong Extension In Revenue Continues | Eli Lilly, Novo Nordisk, Biocon

The final Report will add the analysis of the impact of COVID-19 on this industry

Increasing prevalence of type-2 diabetes is driving the growth of the market. According to American Diabetes Association, in 2014, the economic cost of diabetes globally was estimated to be USD 612 billion. In 2012, in the United States, the cost of diabetes was USD 245 billion.

Global insulin market was valued around 23,400 million in 2017 and is expected to grow with the CAGR of 5.9% in the forecast period. Furthermore, increasing obese population is leading cause of diabetes in the U.S. For instance, according to the Center for Diseases Control and Prevention (CDC), approximately 100 million U.S population has been suffering from Diabetes.

According to the International Diabetes Federation (IDF), in 2015, approximately 415 million people were suffering from diabetes globally, with 90% of the cases of type 2 diabetes, which represents 8.3% of the adult population. According to WHO, rising incidences of diabetes is one of the important drivers for insulin market. In addition, research & development initiatives, technological advancements, and improved healthcare facilities are the key factors fueling the growth of the market.

Grab a Free Sample PDF copy of the Insulin Market Report 2019 @ 
https://straitsresearch.com/report/insulin-market/request-sample

By product type, Short Acting Human Insulin, Intermediate Acting Human Insulin, Long Acting Human Insulin, Fast Acting Human Insulin, Premixed Human Insulin
By Delivery system, Syringes, Pens, Pens needles, Pumps
By application, Type II Diabetes,, Type I Diabetes,, Gestational Diabetes, Prediabetes

View Full Report @ https://straitsresearch.com/report/insulin-market/

Growing Domestic Demand and Expanding Pharmaceutical Sector to Drive the Demand for Insulin in the APAC Region
Asia-Pacific region is anticipated to hold the largest market share in the global Insulin market during the forecast period 2019-2026. The growth in this region can be attributed to the presence of emerging economies like India, China, Japan, Vietnam, and Indonesia, which account for the largest share in this region. India is one of the largest producers of Insulin and a major exporter of the product to various countries across the globe. India accounts for around 80% of the world’s exports of Insulin. The favorable climatic conditions and growth of agricultural inputs and allied services like cold storage and warehousing in India are prompting higher production.

Why buy this report right now?
a. Historical inferences, findings & analysis of the market from 2016 to 2018

b. Projections and performance forecast analysis for the future from 2019 to 2026

c.Production and consumption point of view (POV) analysis

d. Market drivers, restraint and opportunity analysis to define market dynamics covering industry, regulatory, innovation, technological & pricing trends

e. Comprehensive competitive landscape mapping with recent development covering market leadership, competency, sustainability and future prospects

The Major Players Covered in this Report: Eli Lilly, Novo Nordisk, Biocon, Sanofi Aventis, Wockhardt, Julphar, GSK, and SemBioSys., & More...

Buy Full Report with Detail Analysis with COVID-19 Impact @ https://straitsresearch.com/buy-now/insulin-market/global/

Trending Reports of Straits Research –
Pen Needles Market - 
https://www.linkedin.com/posts/veerwati-shukla-035042213_penneedles-therapeutic-hormonal-activity-6826122012830830592-P8hL/

Continuous Blood Glucose Monitoring Market: Information by Product (Receiver, Sensor, and Insulin Pump), End-User (Hospitals and Clinics, Homecare), and Region—Forecast till 2029 | Straits Research
https://straitsresearch.com/report/continuous-blood-glucose-monitoring-market/

Diabetic Ketoacidosis Treatment Market: Information by Treatment Type (Insulin Therapy, Fluid Replacement), End-Users (Hospitals, Specialty Clinics), and Region — Forecast till 2029 | Straits Research
https://straitsresearch.com/report/diabetic-ketoacidosis-treatment-market/

Needle Free Injection Systems Market: Information by Product (Prefilled, Fillable), Technology, Usability, Type of Medication, Delivery Site, and Regional Outlook - Forecast Till 2026 | Straits Research
https://straitsresearch.com/report/needle-free-injection-systems-market/

For more details, please contact us -
Straits Research
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY 10022
Tel: +1 646 480 7505, +44 208 068 9665
Website: https://straitsresearch.com/

About Us:
Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches.

This release was published on openPR.